Advertisement
Among latest findings: Topical losartan helps reduce corneal scarring after injury
Study finds that 11% of those originally deemed ineligible for LASIK are now candidates
Artificially stabilizing hypoxia-inducible factor may stop the damaging effects of hyperoxia in preterm infants
Can a single subretinal injection provide effective treatment?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Faricimab every 16 weeks offers similar benefits as aflibercept every eight weeks
Study shows that intravitreal injections may significantly slow the disease once thought untreatable
Dr. Anand-Apte named Chair for Ophthalmology Research
Patients with genetic mutation need more than ocular treatment
Q&A with Network Chair Daniel F. Martin, MD
Immediate implications for refractive surgery
Advertisement
Advertisement